{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T07:25:29Z","timestamp":1787383529681,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1100600"],"award-info":[{"award-number":["2021YFA1100600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Pearl River Talent Recruitment Program","award":["2019ZT08Y485"],"award-info":[{"award-number":["2019ZT08Y485"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04466-3","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:07:45Z","timestamp":1777385265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extracellular vesicles inherit lactate from aggregated MSCs to alleviate type 1 diabetes mellitus via H2S-induced CD8+ T cell exhaustion"],"prefix":"10.1186","volume":"24","author":[{"given":"Qianhui","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianmin","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengshi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhan","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deqian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueli","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"1","key":"4466_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-025-02313-9","volume":"10","author":"X Han","year":"2025","unstructured":"Han X, et al. Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies. Signal Transduct Target Ther. 2025;10(1):262.","journal-title":"Signal Transduct Target Ther"},{"key":"4466_CR2","doi-asserted-by":"publisher","first-page":"1421854","DOI":"10.3389\/fimmu.2024.1421854","volume":"15","author":"R Mei","year":"2024","unstructured":"Mei R, et al. Advances and clinical challenges of mesenchymal stem cell therapy. Front Immunol. 2024;15:1421854.","journal-title":"Front Immunol"},{"issue":"5","key":"4466_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1089\/ten.teb.2013.0537","volume":"20","author":"S Sart","year":"2014","unstructured":"Sart S, et al. Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications. Tissue Eng Part B Rev. 2014;20(5):365\u201380.","journal-title":"Tissue Eng Part B Rev"},{"issue":"31","key":"4466_CR4","doi-asserted-by":"publisher","first-page":"13724","DOI":"10.1073\/pnas.1008117107","volume":"107","author":"TJ Bartosh","year":"2010","unstructured":"Bartosh TJ, et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A. 2010;107(31):13724\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"4466_CR5","doi-asserted-by":"publisher","first-page":"e2200306","DOI":"10.1002\/smll.202200306","volume":"18","author":"Q Ou","year":"2022","unstructured":"Ou Q, et al. Electrostatic Charge-Mediated Apoptotic Vesicle Biodistribution Attenuates Sepsis by Switching Neutrophil NETosis to Apoptosis. Small. 2022;18(20):e2200306.","journal-title":"Small"},{"issue":"18","key":"4466_CR6","doi-asserted-by":"publisher","first-page":"8926","DOI":"10.7150\/thno.62330","volume":"11","author":"M Xu","year":"2021","unstructured":"Xu M, et al. Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies. Theranostics. 2021;11(18):8926\u201344.","journal-title":"Theranostics"},{"issue":"12","key":"4466_CR7","doi-asserted-by":"publisher","first-page":"e12287","DOI":"10.1002\/jev2.12287","volume":"11","author":"D Jung","year":"2022","unstructured":"Jung D, et al. Reprogramming of T cell-derived small extracellular vesicles using IL2 surface engineering induces potent anti-cancer effects through miRNA delivery. J Extracell Vesicles. 2022;11(12):e12287.","journal-title":"J Extracell Vesicles"},{"issue":"3","key":"4466_CR8","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri3622","volume":"14","author":"PD Robbins","year":"2014","unstructured":"Robbins PD, Morelli AE. Regulation of immune responses by extracellular vesicles. Nat Rev Immunol. 2014;14(3):195\u2013208.","journal-title":"Nat Rev Immunol"},{"issue":"42","key":"4466_CR9","doi-asserted-by":"publisher","first-page":"eadp7872","DOI":"10.1126\/sciadv.adp7872","volume":"10","author":"X Liu","year":"2024","unstructured":"Liu X, et al. Bioenergetic-active exosomes for cartilage regeneration and homeostasis maintenance. Sci Adv. 2024;10(42):eadp7872.","journal-title":"Sci Adv"},{"issue":"20","key":"4466_CR10","doi-asserted-by":"publisher","first-page":"e2300019","DOI":"10.1002\/adhm.202300019","volume":"12","author":"L Liu","year":"2023","unstructured":"Liu L, et al. Mesenchymal Stem Cell Aggregation-Released Extracellular Vesicles Induce CD31(+) EMCN(+) Vessels in Skin Regeneration and Improve Diabetic Wound Healing. Adv Healthc Mater. 2023;12(20):e2300019.","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"4466_CR11","doi-asserted-by":"publisher","first-page":"e12235","DOI":"10.1002\/jev2.12235","volume":"11","author":"X Yuan","year":"2022","unstructured":"Yuan X, et al. Engineering extracellular vesicles by three-dimensional dynamic culture of human mesenchymal stem cells. J Extracell Vesicles. 2022;11(6):e12235.","journal-title":"J Extracell Vesicles"},{"key":"4466_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering5020048","author":"D Egger","year":"2018","unstructured":"Egger D, et al. Dynamic cultivation of mesenchymal stem cell aggregates. Bioengineering. 2018. https:\/\/doi.org\/10.3390\/bioengineering5020048.","journal-title":"Bioengineering"},{"key":"4466_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202415712","author":"L Niu","year":"2025","unstructured":"Niu L, et al. Engineered Foxp1(high) exosomes ameliorates systemic lupus erythematosus. Adv Sci Weinh. 2025. https:\/\/doi.org\/10.1002\/advs.202415712.","journal-title":"Adv Sci Weinh"},{"issue":"11","key":"4466_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41569-024-01045-7","volume":"21","author":"F Porsch","year":"2024","unstructured":"Porsch F, Binder CJ. Autoimmune diseases and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2024;21(11):780\u2013807.","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"4466_CR15","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/90935","volume":"7","author":"P Marrack","year":"2001","unstructured":"Marrack P, Kappler J, Kotzin BL. Autoimmune disease: why and where it occurs. Nat Med. 2001;7(8):899\u2013905.","journal-title":"Nat Med"},{"key":"4466_CR16","doi-asserted-by":"crossref","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2014. 37 Suppl 1: pp. S81\u201390.","DOI":"10.2337\/dc14-S081"},{"issue":"9911","key":"4466_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2014","unstructured":"Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014;383(9911):69\u201382.","journal-title":"Lancet"},{"issue":"656","key":"4466_CR18","doi-asserted-by":"publisher","first-page":"eabg9170","DOI":"10.1126\/scitranslmed.abg9170","volume":"14","author":"X Kou","year":"2022","unstructured":"Kou X, et al. Exocrine pancreas regeneration modifies original pancreas to alleviate diabetes in mouse models. Sci Transl Med. 2022;14(656):eabg9170.","journal-title":"Sci Transl Med"},{"issue":"6","key":"4466_CR19","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.immuni.2012.08.021","volume":"37","author":"TA Doering","year":"2012","unstructured":"Doering TA, et al. Network analysis reveals centrally connected genes and pathways involved in CD8\u2009+\u2009T cell exhaustion versus memory. Immunity. 2012;37(6):1130\u201344.","journal-title":"Immunity"},{"key":"4466_CR20","doi-asserted-by":"crossref","unstructured":"Collier JL et al. Single-cell profiling reveals unique features of diabetogenic T cells in anti-PD-1-induced type 1 diabetes mice. J Exp Med. 2023;220(10):e20221920.","DOI":"10.1084\/jem.20221920"},{"key":"4466_CR21","doi-asserted-by":"publisher","first-page":"682145","DOI":"10.3389\/fendo.2021.682145","volume":"12","author":"W Hu","year":"2021","unstructured":"Hu W, et al. Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes. Front Endocrinol (Lausanne). 2021;12:682145.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"4466_CR22","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.2337\/dc12-0038","volume":"35","author":"N Marek-Trzonkowska","year":"2012","unstructured":"Marek-Trzonkowska N, et al. Administration of CD4\u2009+\u2009CD25highCD127- regulatory T cells preserves \u03b2-cell function in type 1 diabetes in children. Diabetes Care. 2012;35(9):1817\u201320.","journal-title":"Diabetes Care"},{"key":"4466_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.147474","author":"S Dong","year":"2021","unstructured":"Dong S, et al. The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes. JCI Insight. 2021 https:\/\/doi.org\/10.1172\/jci.insight.147474","journal-title":"JCI Insight"},{"issue":"8","key":"4466_CR24","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1111\/dom.14723","volume":"24","author":"M Zieli\u0144ski","year":"2022","unstructured":"Zieli\u0144ski M, et al. Combined therapy with CD4(+) CD25highCD127(-) T regulatory cells and anti-CD20 antibody in recent-onset type 1 diabetes is superior to monotherapy: Randomized phase I\/II trial. Diabetes Obes Metab. 2022;24(8):1534\u201343.","journal-title":"Diabetes Obes Metab"},{"key":"4466_CR25","doi-asserted-by":"publisher","first-page":"216267","DOI":"10.1016\/j.canlet.2023.216267","volume":"567","author":"R Wang","year":"2023","unstructured":"Wang R, et al. Lipid metabolism reprogramming of CD8(+) T cell and therapeutic implications in cancer. Cancer Lett. 2023;567:216267.","journal-title":"Cancer Lett"},{"issue":"18","key":"4466_CR26","doi-asserted-by":"publisher","first-page":"4749","DOI":"10.1073\/pnas.1718217115","volume":"115","author":"E Ahn","year":"2018","unstructured":"Ahn E, et al. Role of PD-1 during effector CD8 T cell differentiation. Proc Natl Acad Sci U S A. 2018;115(18):4749\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4466_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.immuni.2016.07.009","volume":"45","author":"NE Scharping","year":"2016","unstructured":"Scharping NE, et al. The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction. Immunity. 2016;45(2):374\u201388.","journal-title":"Immunity"},{"issue":"10","key":"4466_CR28","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/s42255-020-00280-9","volume":"2","author":"F Franco","year":"2020","unstructured":"Franco F, et al. Metabolic and epigenetic regulation of T-cell exhaustion. Nat Metab. 2020;2(10):1001\u201312.","journal-title":"Nat Metab"},{"key":"4466_CR29","doi-asserted-by":"publisher","first-page":"865782","DOI":"10.3389\/fimmu.2022.865782","volume":"13","author":"S Soltani","year":"2022","unstructured":"Soltani S, et al. Extracellular Vesicle Therapy for Type 1 Diabetes. Front Immunol. 2022;13:865782.","journal-title":"Front Immunol"},{"issue":"3","key":"4466_CR30","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11154-021-09680-y","volume":"23","author":"S Soltani","year":"2022","unstructured":"Soltani S, et al. Diabetes complications and extracellular vesicle therapy. Rev Endocr Metab Disord. 2022;23(3):357\u201385.","journal-title":"Rev Endocr Metab Disord"},{"issue":"4","key":"4466_CR31","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1089\/ten.tec.2009.0432","volume":"16","author":"JE Frith","year":"2010","unstructured":"Frith JE, Thomson B, Genever PG. Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential. Tissue Eng Part C Methods. 2010;16(4):735\u201349.","journal-title":"Tissue Eng Part C Methods"},{"issue":"16","key":"4466_CR32","doi-asserted-by":"publisher","first-page":"3824","DOI":"10.7150\/thno.19890","volume":"7","author":"M Puhka","year":"2017","unstructured":"Puhka M, et al. Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes. Theranostics. 2017;7(16):3824\u201341.","journal-title":"Theranostics"},{"key":"4466_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.114046","volume":"157","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, et al. Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: An emerging field of study to diagnostic and therapeutic purposes. Biomed Pharmacother. 2023;157:114046.","journal-title":"Biomed Pharmacother"},{"key":"4466_CR34","doi-asserted-by":"publisher","DOI":"10.1177\/15330338211037821","volume":"20","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Yang X, Liu H. Extracellular Vesicles in Cancer Metabolism: Implications for Cancer Diagnosis and Treatment. Technol Cancer Res Treat. 2021;20:15330338211037821.","journal-title":"Technol Cancer Res Treat"},{"issue":"3","key":"4466_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/boc.201400081","volume":"107","author":"L Fern\u00e1ndez-Messina","year":"2015","unstructured":"Fern\u00e1ndez-Messina L, et al. Immunomodulatory role of microRNAs transferred by extracellular vesicles. Biol Cell. 2015;107(3):61\u201377.","journal-title":"Biol Cell"},{"issue":"7","key":"4466_CR36","doi-asserted-by":"publisher","first-page":"14240","DOI":"10.3390\/ijms140714240","volume":"14","author":"BN Hannafon","year":"2013","unstructured":"Hannafon BN, Ding WQ. Intercellular communication by exosome-derived microRNAs in cancer. Int J Mol Sci. 2013;14(7):14240\u201369.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"4466_CR37","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.celrep.2017.04.031","volume":"19","author":"A Garcia-Diaz","year":"2017","unstructured":"Garcia-Diaz A, et al. Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression. Cell Rep. 2017;19(6):1189\u2013201.","journal-title":"Cell Rep"},{"issue":"5","key":"4466_CR38","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nm0598-594","volume":"4","author":"L Zitvogel","year":"1998","unstructured":"Zitvogel L, et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med. 1998;4(5):594\u2013600.","journal-title":"Nat Med"},{"issue":"4","key":"4466_CR39","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1172\/JCI81137","volume":"126","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, et al. Dendritic cell-derived exosomes for cancer therapy. J Clin Invest. 2016;126(4):1224\u201332.","journal-title":"J Clin Invest"},{"issue":"3","key":"4466_CR40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00125-003-1089-5","volume":"46","author":"BO Roep","year":"2003","unstructured":"Roep BO. The role of T-cells in the pathogenesis of type 1 diabetes: from cause to cure. Diabetologia. 2003;46(3):305\u201321.","journal-title":"Diabetologia"},{"issue":"3","key":"4466_CR41","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41574-020-00443-4","volume":"17","author":"BO Roep","year":"2021","unstructured":"Roep BO, et al. Type 1 diabetes mellitus as a disease of the \u03b2-cell (do not blame the immune system?). Nat Rev Endocrinol. 2021;17(3):150\u201361.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"4466_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2249.2012.04635.x","volume":"170","author":"JR Abreu","year":"2012","unstructured":"Abreu JR, et al. CD8 T cell autoreactivity to preproinsulin epitopes with very low human leucocyte antigen class I binding affinity. Clin Exp Immunol. 2012;170(1):57\u201365.","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"4466_CR43","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2337\/dc15-0144","volume":"38","author":"MA Atkinson","year":"2015","unstructured":"Atkinson MA, et al. Current concepts on the pathogenesis of type 1 diabetes\u2013considerations for attempts to prevent and reverse the disease. Diabetes Care. 2015;38(6):979\u201388.","journal-title":"Diabetes Care"},{"issue":"4","key":"4466_CR44","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.molcel.2023.12.015","volume":"84","author":"X Wang","year":"2024","unstructured":"Wang X, et al. A GAPDH serotonylation system couples CD8(+) T cell glycolytic metabolism to antitumor immunity. Mol Cell. 2024;84(4):760\u2013e7757.","journal-title":"Mol Cell"},{"issue":"2","key":"4466_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","volume":"40","author":"S Kumagai","year":"2022","unstructured":"Kumagai S, et al. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments. Cancer Cell. 2022;40(2):201\u2013e2189.","journal-title":"Cancer Cell"},{"issue":"6","key":"4466_CR46","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41590-021-00940-2","volume":"22","author":"Y Guo","year":"2021","unstructured":"Guo Y, et al. Metabolic reprogramming of terminally exhausted CD8(+) T cells by IL-10 enhances anti-tumor immunity. Nat Immunol. 2021;22(6):746\u201356.","journal-title":"Nat Immunol"},{"issue":"7","key":"4466_CR47","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","volume":"5","author":"KM Tharp","year":"2024","unstructured":"Tharp KM, et al. Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment. Nat Cancer. 2024;5(7):1045\u201362.","journal-title":"Nat Cancer"},{"issue":"14","key":"4466_CR48","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-22-3042","volume":"83","author":"X Huang","year":"2023","unstructured":"Huang X, et al. Metformin Reprograms Tryptophan Metabolism to Stimulate CD8\u2009+\u2009T-cell Function in Colorectal Cancer. Cancer Res. 2023;83(14):2358\u201371.","journal-title":"Cancer Res"},{"issue":"7","key":"4466_CR49","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1016\/j.cell.2020.11.009","volume":"183","author":"AE Ringel","year":"2020","unstructured":"Ringel AE, et al. Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity. Cell. 2020;183(7):1848\u2013e186626.","journal-title":"Cell"},{"issue":"9","key":"4466_CR50","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.immuni.2024.08.003","volume":"57","author":"Y Ping","year":"2024","unstructured":"Ping Y, et al. PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8(+) T cell ferroptosis. Immunity. 2024;57(9):2122\u2013e21399.","journal-title":"Immunity"},{"issue":"5","key":"4466_CR51","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.immuni.2024.03.021","volume":"57","author":"J Xiao","year":"2024","unstructured":"Xiao J, et al. 25-Hydroxycholesterol regulates lysosome AMP kinase activation and metabolic reprogramming to educate immunosuppressive macrophages. Immunity. 2024;57(5):1087\u2013104. .e7.","journal-title":"Immunity"},{"key":"4466_CR52","doi-asserted-by":"publisher","first-page":"105119","DOI":"10.1016\/j.phrs.2020.105119","volume":"161","author":"N Dilek","year":"2020","unstructured":"Dilek N, et al. Hydrogen sulfide: An endogenous regulator of the immune system. Pharmacol Res. 2020;161:105119.","journal-title":"Pharmacol Res"},{"issue":"2","key":"4466_CR53","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.immuni.2015.07.017","volume":"43","author":"R Yang","year":"2015","unstructured":"Yang R, et al. Hydrogen Sulfide Promotes Tet1- and Tet2-Mediated Foxp3 Demethylation to Drive Regulatory T Cell Differentiation and Maintain Immune Homeostasis. Immunity. 2015;43(2):251\u201363.","journal-title":"Immunity"},{"issue":"1","key":"4466_CR54","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cmet.2023.11.012","volume":"36","author":"Q Ou","year":"2024","unstructured":"Ou Q, et al. Apoptosis releases hydrogen sulfide to inhibit Th17 cell differentiation. Cell Metab. 2024;36(1):78\u2013e895.","journal-title":"Cell Metab"},{"issue":"4","key":"4466_CR55","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1158\/0008-5472.CAN-22-1837","volume":"83","author":"T Yue","year":"2023","unstructured":"Yue T, et al. Hydrogen Sulfide Creates a Favorable Immune Microenvironment for Colon Cancer. Cancer Res. 2023;83(4):595\u2013612.","journal-title":"Cancer Res"},{"issue":"2","key":"4466_CR56","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1159\/000489980","volume":"47","author":"XL Wang","year":"2018","unstructured":"Wang XL, et al. Endogenous Hydrogen Sulfide Ameliorates NOX4 Induced Oxidative Stress in LPS-Stimulated Macrophages and Mice. Cell Physiol Biochem. 2018;47(2):458\u201374.","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"4466_CR57","first-page":"60","volume":"31","author":"KR Olson","year":"2016","unstructured":"Olson KR, Straub KD. The role of hydrogen sulfide in evolution and the evolution of hydrogen sulfide in metabolism and signaling. Physiol (Bethesda). 2016;31(1):60\u201372.","journal-title":"Physiol (Bethesda)"},{"issue":"12","key":"4466_CR58","doi-asserted-by":"publisher","first-page":"6663","DOI":"10.1073\/pnas.1919211117","volume":"117","author":"MA Rahman","year":"2020","unstructured":"Rahman MA, et al. Hydrogen sulfide dysregulates the immune response by suppressing central carbon metabolism to promote tuberculosis. Proc Natl Acad Sci U S A. 2020;117(12):6663\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"4466_CR59","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13062-025-00645-8","volume":"20","author":"YY Shao","year":"2025","unstructured":"Shao YY, et al. Downregulation of PD-L1 expression by Wnt pathway inhibition to enhance PD-1 blockade efficacy in hepatocellular carcinoma. Biol Direct. 2025;20(1):49.","journal-title":"Biol Direct"},{"key":"4466_CR60","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.3389\/fimmu.2019.02293","volume":"10","author":"X Li","year":"2019","unstructured":"Li X, et al. WNT\/\u03b2-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment. Front Immunol. 2019;10:2293.","journal-title":"Front Immunol"},{"issue":"1","key":"4466_CR61","doi-asserted-by":"publisher","first-page":"e0147018","DOI":"10.1371\/journal.pone.0147018","volume":"11","author":"L Guo","year":"2016","unstructured":"Guo L, et al. Hydrogen sulfide inhibits transforming growth factor-\u03b21-induced EMT via Wnt\/catenin pathway. PLoS One. 2016;11(1):e0147018.","journal-title":"PLoS One"},{"issue":"7","key":"4466_CR62","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1016\/j.celrep.2020.01.076","volume":"30","author":"CE Rudd","year":"2020","unstructured":"Rudd CE, Chanthong K, Taylor A. Small Molecule Inhibition of GSK-3 Specifically Inhibits the Transcription of Inhibitory Co-receptor LAG-3 for Enhanced Anti-tumor Immunity. Cell Rep. 2020;30(7):2075\u2013e20824.","journal-title":"Cell Rep"},{"key":"4466_CR63","doi-asserted-by":"publisher","DOI":"10.1242\/dev.193417","author":"GA Quaife-Ryan","year":"2020","unstructured":"Quaife-Ryan GA, et al. \u03b2-Catenin drives distinct transcriptional networks in proliferative and nonproliferative cardiomyocytes. Development. 2020. https:\/\/doi.org\/10.1242\/dev.193417.","journal-title":"Development"},{"issue":"2","key":"4466_CR64","doi-asserted-by":"publisher","first-page":"e0117097","DOI":"10.1371\/journal.pone.0117097","volume":"10","author":"J Xu","year":"2015","unstructured":"Xu J, et al. \u03b2-catenin is required for the tumorigenic behavior of triple-negative breast cancer cells. PLoS One. 2015;10(2):e0117097.","journal-title":"PLoS One"},{"issue":"1","key":"4466_CR65","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12951-025-03592-8","volume":"23","author":"B Yang","year":"2025","unstructured":"Yang B, et al. Lyophilized apoptotic vesicles restore DNA damage and mitochondria dysfunction to ameliorate radiation enteritis. J Nanobiotechnol. 2025;23(1):521.","journal-title":"J Nanobiotechnol"},{"key":"4466_CR66","first-page":"626","volume":"19","author":"L Ma","year":"2023","unstructured":"Ma L, et al. Apoptotic extracellular vesicles are metabolized regulators nurturing the skin and hair. Bioact Mater. 2023;19:626\u201341.","journal-title":"Bioact Mater"}],"updated-by":[{"DOI":"10.1186\/s12951-026-04905-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000}}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04466-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04466-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04466-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T07:02:12Z","timestamp":1787382132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04466-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4466"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04466-3","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: fig. 2 has been updated.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12951-026-04905-1","URL":"https:\/\/doi.org\/10.1186\/s12951-026-04905-1","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were in accordance with the ethics committees of Sun Yat-sen University, China. The mesenchymal stem cells used in this study were approved by the Medical Ethics Committee of the Hospital of Stomatology, Sun Yat-Sen University, China.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agreed to publish this manuscript.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"566"}}